Annual report pursuant to Section 13 and 15(d)

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.21.1
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - 4 months ended Dec. 31, 2020 - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning, Shares at Aug. 19, 2020      
Balance at beginning, Value at Aug. 19, 2020
Common stock issued to Sponsor, Shares 2,875,000      
Common stock issued to Sponsor,Value $ 288 24,712 25,000
Sale of 10,000,000 Units in Initial Public Offering, Shares 10,000,000      
Sale of 10,000,000 Units in Initial Public Offering, Value $ 1,000 99,999,000 100,000,000
Sale of 500,000 Private Units to Sponsor in private placement, Shares 500,000      
Sale of 500,000 Private Units to Sponsor in private placement, Value $ 50 4,999,950 5,000,000
Sale of 1,500,000 Units through over-allotment, Shares 1,500,000      
Sale of 1,500,000 Units through over-allotment, Value $ 150 14,999,850 15,000,000
Sale of 45,000 Private Units to Sponsor in private placement, Shares 45,000      
Sale of 45,000 Private Units to Sponsor in private placement, Value $ 5 449,995 450,000
Underwriting fee (2,300,000) (2,300,000)
Deferred underwriting fee (4,025,000) (4,025,000)
Offering costs charged to the stockholders' equity (406,655) (406,655)
Change in common stock subject to possible redemption, Shares (10,746,599)      
Change in common stock subject to possible redemption, Value $ (1,075) (108,539,579) (108,540,654)
Net loss (202,686) (202,686)
Balance at ending, Shares at Dec. 31, 2020 4,173,401      
Balance at ending, Value at Dec. 31, 2020 $ 418 $ 5,202,273 $ (202,686) $ 5,000,005